NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)

Technical Analysis Report for NASDAQ stock KPTI Karyopharm Therapeutics. Dated: 26 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics

Karyopharm Therapeutics Opened at 5.08 and Closed at: 5.57, which is 6.46% of previous session's close. It moved within a range of 5.00 and 5.61
The session was a Bullish session with an average volume of 4207900, which is 60.66% of previous session's volumes.

• Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
• Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

A Dead cross was found 3 days back on mid term averages

Support for tomorrow is 5.29 and resistance for tomorrow is 5.9
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 5.18, 4.78 resistance for tomorrow's hourly charts is 5.79, 6

10 Day SMA for Karyopharm Therapeutics (KPTI) is 7.1 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Karyopharm Therapeutics (KPTI) is 8.03 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Karyopharm Therapeutics (KPTI) is 7.72 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 7.06 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Karyopharm Therapeutics is 6.25 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Karyopharm Therapeutics is at 8.03 and 200 DMA is at 6.25, while 50 DMA and 100 DMA are at 7.72 and 7.06 respectively

Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 8.03 and 20 EMA is at 7.51

Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 7.72 and 50 EMA is at 7.68

Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 7.06 and 100 EMA is at 7.24

Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 6.25 and 200 EMA is at 6.26

Sanofi has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Sanofi, about 36.85% more returns!

Rockwell Medical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 41.51% more returns!

Ultragenyx Pharmaceutical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 27.19% more returns!

Karyopharm Therapeutics has performed better than Outlook Therapeutics in short term. Holding Karyopharm Therapeutics could be a better choice for now!

Minerva Neurosciences has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 38.99% more returns!

Marker Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Marker Therapeutics, about 25.87% more returns!

Meiragtx Holdings has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 38.73% more returns!

Mimedx Group has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Mimedx Group, about 20.19% more returns!

Iterum Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Iterum Therapeutics, about 15.43% more returns!

Ironwood Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 26.5% more returns!

Gilead Sciences has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 35.64% more returns!

Fonar Corporation has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Fonar Corporation, about 40.27% more returns!

Esperion Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Esperion Therapeutics, about 25.55% more returns!

Corbus Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Corbus Pharmaceuticals, about 52.43% more returns!

Cogentix Medical has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Cogentix Medical, about 55.55% more returns!

Biocryst Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Biocryst Pharmaceuticals, about 61.44% more returns!

Aurinia Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 45.01% more returns!

Allogene Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 29.07% more returns!

Akebia Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 45.73% more returns!

Karyopharm Therapeutics Technical analysis of indicators

Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Karyopharm Therapeutics in short term and the sell signal is strong.

Karyopharm Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Karyopharm Therapeutics in short term but BUY signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 5.88 and Karyopharm Therapeutics KPTI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.

Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And KPTI Experts View which covers a lot of information including buying and selling signals

KPTI future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet